These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6282189)

  • 21. [Arterial hypertension. Physiopathologic approach by means of the renin-angiotensin-aldosterone and kallikrein-kinin-prostaglandin systems].
    Antón Aranda E; Martí Cabane J; Tiberio López G
    Rev Clin Esp; 1983 Jun 15-30; 169(5-6):287-91. PubMed ID: 6555850
    [No Abstract]   [Full Text] [Related]  

  • 22. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
    Williams GH; Hollenberg NK
    J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the mechanism of action of angiotensin converting enzyme inhibitors on the dog kidney].
    Omosu M
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):883-94. PubMed ID: 1484407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs inhibiting the renin - angiotensin system.
    Antonaccio MJ; Cushman DW
    Fed Proc; 1981 Jun; 40(8):2275-84. PubMed ID: 6263716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
    Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 29. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine mechanisms in the pathogenesis of essential hypertension. III. Special reference on the interrelations between the prostaglandin and kallikrein-kinin systems.
    Păuşescu E
    Physiologie; 1981; 18(2):141-52. PubMed ID: 6791173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What have we learned about inhibitors of the renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
    Robertson JI
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S2-8. PubMed ID: 2422488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition.
    Overlack A; Stumpe KO; Kühnert M; Kolloch R; Ressel C; Heck I; Krück F
    Klin Wochenschr; 1981 Jan; 59(2):69-74. PubMed ID: 6163004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors: mechanistic controversies.
    Ujhelyi MR; Ferguson RK; Vlasses PH
    Pharmacotherapy; 1989; 9(6):351-62. PubMed ID: 2559394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitors in heart failure.
    Borek M; Charlap S; Frishman WH
    Med Clin North Am; 1989 Mar; 73(2):315-38. PubMed ID: 2645479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interference of converting enzyme inhibitors with the kallikrein-kinin system.
    Carretero OA; Orstavik TB; Rabito SF; Scicli AG
    Clin Exp Hypertens A; 1983; 5(7-8):1277-85. PubMed ID: 6315269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kinins and prostaglandins in hypertension.
    Abe K
    Clin Endocrinol Metab; 1981 Nov; 10(3):577-605. PubMed ID: 6284417
    [No Abstract]   [Full Text] [Related]  

  • 38. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1980 Dec; 20(6):409-52. PubMed ID: 7009133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine profile in the long-term phase of converting-enzyme inhibition.
    Swartz SL; Williams GH; Hollenberg NK; Crantz FR; Moore TJ; Levine L; Sasahara AA; Dluhy RG
    Clin Pharmacol Ther; 1980 Oct; 28(4):499-508. PubMed ID: 6250761
    [No Abstract]   [Full Text] [Related]  

  • 40. Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts.
    Lant AF
    Br J Clin Pharmacol; 1987; 23 Suppl 1(Suppl 1):27S-41S. PubMed ID: 3034317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.